Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma

Author： Heaton Pamela C.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.8, 2006-01, pp. : 727-742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 585-595

Adis International

Access to resources Recommend Favorite

Treating Asthma in the Older Patient: Is There a Place for Leukotriene Modifiers?

By Grayson Mitchell H.   Korenblat Phillip E.  

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Asthma Management Strategies

By Thomas M.   Haughney J.   Price D.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 789-789

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite